UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
PharmAbcine registers 1st patient for phase-2 trial on olinvacimab
by Jeong Sae-im
2019-11-19 17:18
‘New law needed to curb rising chronic kidney disease’
by Jeong Sae-im
2019-11-19 11:45
‘Udenafil improved exercise in single ventricle heart disease’
by Jeong Sae-im
2019-11-18 14:48
Prosecutors raid drugmakers, distributors for suspected bid-rigging
by Jeong Sae-im
2019-11-14 15:27
How can Korean drugmakers enter Europe successfully?
by Jeong Sae-im
2019-11-13 15:22
라인
Samsung Bioepis expects ₩1 trillion biosimilar sales this year
by Jeong Sae-im
2019-11-13 15:21
[News Focus] ‘FDA could allow resumption of Invossa trial’
by Jeong Sae-im
2019-11-12 15:48
Eunpyeong St. Mary’s Hospital adopts AI nursing documentation
by Jeong Sae-im
2019-11-12 15:47
Genexine’s new immunotherapy shows stability even in high dose
by Jeong Sae-im
2019-11-11 13:36
‘Cancer patients suffered side effects after taking anthelmintic drug’
by Jeong Sae-im
2019-11-08 13:30
라인
‘Lung cancer screening was effective in numerous studies’
by Jeong Sae-im
2019-11-07 14:06
Court rejects arrest warrant for 2 Kolon execs
by Jeong Sae-im
2019-11-05 13:54
Yuhan, Dong-A, HanAll see Q3 earnings jump on licensing-out deals
by Jeong Sae-im
2019-11-04 15:52
Kolon allegedly knew Inovossa mislabeling before applying for approval
by Jeong Sae-im
2019-11-01 15:07
Prosecutors seek to arrest 2 Kolon execs for false Invossa data
by Jeong Sae-im
2019-10-31 15:34
라인
Regulator to do quality test on botulinum toxin products
by Jeong Sae-im
2019-10-31 14:24
Syntekabio passes prior review for Kosdaq listing
by Jeong Sae-im
2019-10-31 13:27
71 pharmaceutical CEOs gather to boost new drug development
by Jeong Sae-im
2019-10-30 12:40
Prosecution seeks jail term for Samsung execs for destroying evidence
by Jeong Sae-im
2019-10-29 13:10
KangStem Biotech changes strategy for atopic dermatitis drug
by Jeong Sae-im
2019-10-28 15:34
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top